SRPT vs. ANF
Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and Abercrombie & Fitch Co. (ANF).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SRPT or ANF.
Key characteristics
| SRPT | ANF | |
|---|---|---|
| YTD Return | 22.20% | 58.98% |
| 1Y Return | 48.32% | 109.42% |
| 3Y Return (Ann) | 11.60% | 45.63% |
| 5Y Return (Ann) | 3.14% | 51.79% |
| 10Y Return (Ann) | 22.71% | 20.00% |
| Sharpe Ratio | 1.00 | 1.98 |
| Sortino Ratio | 2.12 | 2.51 |
| Omega Ratio | 1.26 | 1.33 |
| Calmar Ratio | 0.88 | 3.39 |
| Martin Ratio | 3.57 | 7.07 |
| Ulcer Index | 13.68% | 15.58% |
| Daily Std Dev | 48.93% | 55.65% |
| Max Drawdown | -98.17% | -86.59% |
| Current Drawdown | -34.07% | -27.08% |
Fundamentals
| SRPT | ANF | |
|---|---|---|
| Market Cap | $11.62B | $7.16B |
| EPS | $1.54 | $9.42 |
| PE Ratio | 78.97 | 14.89 |
| PEG Ratio | 159.25 | -24.52 |
| Total Revenue (TTM) | $1.64B | $3.61B |
| Gross Profit (TTM) | $1.40B | $2.29B |
| EBITDA (TTM) | $70.22M | $663.14M |
Correlation
The correlation between SRPT and ANF is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SRPT vs. ANF - Performance Comparison
In the year-to-date period, SRPT achieves a 22.20% return, which is significantly lower than ANF's 58.98% return. Over the past 10 years, SRPT has outperformed ANF with an annualized return of 22.71%, while ANF has yielded a comparatively lower 20.00% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SRPT vs. ANF - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Abercrombie & Fitch Co. (ANF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SRPT vs. ANF - Dividend Comparison
Neither SRPT nor ANF has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ANF Abercrombie & Fitch Co. | 0.00% | 0.00% | 0.00% | 0.00% | 0.98% | 4.63% | 3.99% | 4.59% | 6.67% | 2.96% | 2.79% | 2.43% |
Drawdowns
SRPT vs. ANF - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, which is greater than ANF's maximum drawdown of -86.59%. Use the drawdown chart below to compare losses from any high point for SRPT and ANF. For additional features, visit the drawdowns tool.
Volatility
SRPT vs. ANF - Volatility Comparison
The current volatility for Sarepta Therapeutics, Inc. (SRPT) is 9.19%, while Abercrombie & Fitch Co. (ANF) has a volatility of 13.06%. This indicates that SRPT experiences smaller price fluctuations and is considered to be less risky than ANF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SRPT vs. ANF - Financials Comparison
This section allows you to compare key financial metrics between Sarepta Therapeutics, Inc. and Abercrombie & Fitch Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities